Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per carton), NDC 57664-135-64, b) 100-count unit dose Capsules (25x4 blister cards per carton), NDC 57664-135-65, Distributed by: Caraco Pharmaceutical Laboratories, Ltd. Detroit, MI 48202 Affiliate of Sun Pharmaceutical Industries, Inc.
Published October 10, 2012 · Recall initiated: August 21, 2012
Summary
FDA records drug Class II recall D-003-2013, published October 10, 2012 and initiated August 21, 2012. Recalling firm: Caraco Pharmaceutical Laboratories Ltd.; Status: Terminated; Reported quantity: a) 2424 Cartons b) 2675 Cartons; Lot: Lot: a) 3305.039B, Exp 07/13; b) 3305.039A, Exp 07/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Crystallization: Presence of crystals of Nimodipine within the capsule solution.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Caraco Pharmaceutical Laboratories Ltd.
- Distributor
- One direct account - Caraco Pharmaceutical Labroatories, LTD Detroit, Michigan 78 sub accounts
- Lot
- Lot: a) 3305.039B, Exp 07/13; b) 3305.039A, Exp 07/13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOxcarbazepine Tablets, 300 mg, 100 tablet bottles, Rx Only. Distributed by: Caraco PharmaceuticalFebruary 19, 2014
- FDAbuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, UD 100 Tablets (10 x 10) per carton, Rx only,October 10, 2012
- FDAChloraPrep One-Step (2% w/v chlorhexidine gluconate and 70% v/v isopropyl alcohol) Patient Preoperative SkinOctober 10, 2012
- FDAbuPROPion Hydrochloride Extended-Release Tablets (XL), 150 mg, UD 100 Tablets (10 x 10) per carton, Rx only,October 10, 2012
- FDAFamotidine Tablets USP, 20 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505October 10, 2012
- FDAMarathon Flow Directed Micro Catheter, Model #105-5055. Product Usage: The Marathon Flow Directed MicroOctober 3, 2012
Questions about this recall
Was Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per carton), NDC 57664-135-64, b) 100-count unit dose Capsules (25x4 blister cards per carton), NDC 57664-135-65, Distributed by: Caraco Pharmaceutical Laboratories, Ltd. Detroit, MI 48202 Affiliate of Sun Pharmaceutical Industries, Inc. recalled?
Yes. FDA published recall D-003-2013 on October 10, 2012. Reported hazard: Crystallization: Presence of crystals of Nimodipine within the capsule solution.
What should I do if I have this product?
Voluntary: Firm initiated · Letter